Csenge Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.75M | Buy |
10,362
+943
| +10% | +$323K | 0.15% | 128 |
|
|
2026
Q1 | $3.31M | Sell |
9,419
-1,109
| -11% | -$395K | 0.15% | 127 |
|
|
2025
Q4 | $3.45M | Buy |
10,528
+2,099
| +25% | +$666K | 0.16% | 124 |
|
|
2025
Q3 | $2.38M | Buy |
8,429
+2,046
| +32% | +$593K | 0.11% | 157 |
|
|
2025
Q2 | $1.84M | Buy |
6,383
+40
| +0.6% | +$11.3K | 0.1% | 169 |
|
|
2025
Q1 | $1.76M | Buy |
6,343
+204
| +3% | +$60.2K | 0.1% | 167 |
|
|
2024
Q4 | $1.6M | Sell |
6,139
-938
| -13% | -$278K | 0.09% | 186 |
|
|
2024
Q3 | $2.32M | Buy |
7,077
+231
| +3% | +$75.6K | 0.12% | 139 |
|
|
2024
Q2 | $2.14M | Buy |
6,846
+97
| +1% | +$28.5K | 0.12% | 128 |
|
|
2024
Q1 | $1.92M | Sell |
6,749
-184
| -3% | -$53.8K | 0.11% | 152 |
|
|
2023
Q4 | $2M | Buy |
6,933
+1,716
| +33% | +$468K | 0.12% | 139 |
|
|
2023
Q3 | $1.4M | Buy |
5,217
+2,405
| +86% | +$600K | 0.1% | 172 |
|
|
2023
Q2 | $624K | Buy |
2,812
+219
| +8% | +$50.8K | 0.04% | 319 |
|
|
2023
Q1 | $627K | Buy |
2,593
+150
| +6% | +$36.8K | 0.05% | 293 |
|
|
2022
Q4 | $642K | Buy |
2,443
+74
| +3% | +$19.8K | 0.05% | 291 |
|
|
2022
Q3 | $534K | Sell |
2,369
-184
| -7% | -$44.6K | 0.04% | 319 |
|
|
2022
Q2 | $621K | Buy |
2,553
+346
| +16% | +$84.8K | 0.05% | 299 |
|
|
2022
Q1 | $534K | Sell |
2,207
-217
| -9% | -$49.9K | 0.04% | 367 |
|
|
2021
Q4 | $599K | Sell |
2,424
-8
| -0.3% | -$1.69K | 0.05% | 304 |
|
|
2021
Q3 | $520K | Buy |
2,432
+8
| +0.3% | +$1.84K | 0.04% | 353 |
|
|
2021
Q2 | $599K | Buy |
2,424
+392
| +19% | +$96.4K | 0.05% | 305 |
|
|
2021
Q1 | $506K | Sell |
2,032
-738
| -27% | -$176K | 0.05% | 272 |
|
|
2020
Q4 | $637K | Sell |
2,770
-812
| -23% | -$187K | 0.08% | 190 |
|
|
2020
Q3 | $905K | Sell |
3,582
-73
| -2% | -$18.1K | 0.12% | 141 |
|
|
2020
Q2 | $862K | Buy |
3,655
+1,662
| +83% | +$379K | 0.12% | 130 |
|
|
2020
Q1 | $404K | Sell |
1,993
-232
| -10% | -$50.7K | 0.11% | 168 |
|
|
2019
Q4 | $536K | Sell |
2,225
-29
| -1% | -$6.39K | 0.14% | 150 |
|
|
2019
Q3 | $436K | Buy |
2,254
+190
| +9% | +$36.5K | 0.12% | 159 |
|
|
2019
Q2 | $380K | Buy |
2,064
+71
| +4% | +$12.7K | 0.13% | 122 |
|
|
2019
Q1 | $378K | Sell |
1,993
-1,693
| -46% | -$323K | 0.13% | 121 |
|
|
2018
Q4 | $717K | Buy |
3,686
+245
| +7% | +$47.8K | 0.26% | 76 |
|
|
2018
Q3 | $655K | Sell |
3,441
-1,206
| -26% | -$238K | 0.25% | 73 |
|
|
2018
Q2 | $858K | Sell |
4,647
-781
| -14% | -$138K | 0.32% | 80 |
|
|
2018
Q1 | $925K | Buy |
5,428
+480
| +10% | +$88.1K | 0.32% | 76 |
|
|
2017
Q4 | $860K | Sell |
4,948
-710
| -13% | -$126K | 0.31% | 82 |
|
|
2017
Q3 | $1.05M | Buy |
+5,658
| New | +$1M | 0.42% | 65 |
|
Other funds holding AMGN
Csenge Advisory Group's AMGN Position: Q2 2026 in Review
Csenge Advisory Group increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $323K and bringing the position to 10,362 shares worth $3.75M. The position accounts for 0.15% of the portfolio, ranked #128.
Csenge Advisory Group first reported a position in AMGN in Q3 2017 and has held it in 36 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Csenge Advisory Group held 10,362 shares of Amgen worth $3.75M as of Q2 2026.
- Csenge Advisory Group bought 943 Amgen shares in Q2 2026, an estimated $323K.
- Amgen made up 0.15% of Csenge Advisory Group's portfolio in Q2 2026, its #128 holding.
- Csenge Advisory Group first reported a position in Amgen in Q3 2017 and has held it in 36 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.